International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.
Non-inflammatory cystic lesions of the pancreas are increasingly recognized. Two distinct entities have been defined, i.e., intraductal papillary mucinous neoplasm (IPMN) and mucinous cystic neoplasm (MCN). Ovarian-type stroma has been proposed as a requisite to distinguish MCN from IPMN. Some other distinct features to characterize IPMN and MCN have been identified, but there remain ambiguities between the two diseases. In view of the increasing frequency with which these neoplasms are being diagnosed worldwide, it would be helpful for physicians managing patients with cystic neoplasms of the pancreas to have guidelines for the diagnosis and treatment of IPMN and MCN. The proposed guidelines represent a consensus of the working group of the International Association of Pancreatology.
Tanaka
Masao
M
Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. masaotan@med.kyushu-u.ac.jp
Chari
Suresh
S
Adsay
Volkan
V
Fernandez-del Castillo
Carlos
C
Falconi
Massimo
M
Shimizu
Michio
M
Yamaguchi
Koji
K
Yamao
Kenji
K
Matsuno
Seiki
S
D013507:Endocrine Surgical Procedures; D006801:Humans; D018297:Neoplasms, Cystic, Mucinous, and Serous / Q000145:classification / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D010190:Pancreatic Neoplasms / Q000145:classification / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D018300:Papilloma, Intraductal / Q000145:classification / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*